• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Quotient Clinical - Articles and news items

Whitepaper: Accelerating development of enabled formulations for poorly soluble drugs

Whitepaper: Accelerating development of enabled formulations for poorly soluble drugs

Whitepapers, Z Homepage promo / 20 February 2017 / Quotient Clinical

In this whitepaper, Quotient Clinical discuss poorly soluble drugs and how they have developed an innovative approach to identify and overcome these solubility challenges…

Spray drying – various challenges, one solution?

Issue 6 2016 / 13 December 2016 / Nikki Whitfield, Quotient Clinical

Spray drying is a proven, flexible and scalable process used within the pharmaceutical industry to address a wide range of formulation and drug delivery challenges. Its versatility has been proven through applications to both small chemical and biopharmaceutical drugs for product delivery via multiple routes of administration. The technique is used to address stability challenges associated with temperature-sensitive molecules such as proteins and peptides, as well as providing innovative solutions for particle size critical applications such as inhaled drug delivery. In addition, the technology is now a primary formulation strategy to address an increasingly prevalent challenge in the industry: the successful oral delivery of poorly soluble compounds.

Quotient Clinical

Quotient Clinical hosts formulation development and drug delivery seminar series

Supplier news / 15 June 2016 / Quotient Clinical

Quotient Clinical, the Translational Pharmaceutics® company, is holding a series of formulation development and drug delivery seminars this June and July…

Quotient Clinical

Quotient Clinical and Upperton announce a spray drying partnership to deliver integrated formulation development and GMP manufacturing programs for poorly soluble drugs

Supplier news / 4 May 2016 / Quotient Clinical

Quotient Clinical and Upperton have announced a partnership to address drug delivery challenges…

Quotient Clinical

Quotient Clinical incorporates Japanese bridging into a Translational Pharmaceutics® program

Supplier news / 15 March 2016 / Quotient Clinical

Quotient Clinical has announced the completion of its first clinical program involving Japanese healthy volunteers…

Quotient Clinical

Quotient Clinical showcases Enabled-First-in-Human® programs at ASCPT 2016

Supplier news / 1 March 2016 / Quotient Clinical

Quotient Clinical will be showcasing its Enabled-First-in-Human® programs at the upcoming ASCPT Meeting 2016…

Quotient Clinical

Quotient Clinical celebrates its 100th RapidFACT® program

Supplier news / 11 February 2016 / Quotient Clinical

Quotient Clinical, the Translational Pharmaceutics® company, has announced that it has completed its 100th RapidFACT (Rapid Formulation development And Clinical Testing) program – a significant milestone in the growth of this service, which addresses drug R&D productivity issues…

Quotient Clinical

Quotient Clinical expands its formulation development services with the acquisition of Co-Formulate

Supplier news / 16 December 2015 / Quotient Clinical

Quotient Clinical, the Translational Pharmaceutics® company, has announced that it has acquired formulation development specialist Co-Formulate Limited…

Quotient Clinical

Quotient Clinical showcases Translational Pharmaceutics and RapidFACT at AAPS 2015

Supplier news / 13 October 2015 / Quotient Clinical

Quotient Clinical, the Translational Pharmaceutics® company, will be highlighting the benefits of its unique, integrated approach to formulation development, real-time adaptive manufacturing and clinical testing on booth 1662…

Quotient Clinical CEO Mark Egerton a winner at UK EY Entrepreneur of the Year 2015 awards

Quotient Clinical CEO Mark Egerton a winner at UK EY Entrepreneur of the Year 2015 awards

Supplier news / 13 October 2015 / Quotient Clinical

Quotient Clinical has announced that CEO Mark Egerton has received an EY Entrepreneur of the Year® 2015 UK Award…

Quotient Clinical’s Chief Scientific Officer awarded honorary professorship at the University of Nottingham

Supplier news / 12 August 2015 / Quotient Clinical

Quotient Clinical, the Translational Pharmaceutics® Company, has announced that Dr Peter Scholes, its Chief Scientific Officer, has been awarded an honorary professorship in the School of Pharmacy at the University of Nottingham…

Quotient Clinical

Quotient Clinical announces expansion of pharmaceutical sciences capacity

Supplier news / 14 July 2015 / Quotient Clinical

Quotient Clinical, the Translational Pharmaceutics® Company, has announced a significant expansion of its pharmaceutical sciences capabilities…